1. Market Research
  2. > Healthcare Market Trends
  3. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Switzerland

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Switzerland
SWITZERLAND ..1
HEALTHCARE SYSTEM..1
Facts and Figures ..1
Market Indicators2
Provision and Funding ...4
Compulsory Health Insurance .5
Complementary Health Insurance...6
Regulation and Funding ..6
Ambulatory and Hospital Care.6
PRICING...7
Prescription Drugs..7
Applications .7
Decision...8
Equivalent Drugs .9
Innovation Bonus.9
International Price Comparison .10
Timelines ...10
Price Reviews 10
Generic Drugs ..10
Current Process.11
Proposed Changes11
Price Reviews 12
Hospital Drugs..12
OTC Drugs ...13
REIMBURSEMENT 13
Admission to Reimbursement ..13
Swissmedic Classifications13
Applications ...14
Procedure ..14
Decision.15
Reimbursement Restrictions .16
Reimbursement Categories .16
Reimbursement Prices.16
Hospital Reimbursement..16
Formularies16
Funding..17
Changes in Reimbursement Status .17
Triennial Reviews ..17
Health 2020 Reviews.17
Changes in Reimbursement Prices .18
Background18
Price Increases..19
Triennial Reviews ..19
Patent Expiry Reviews...21
Exceptional Reviews .21
Indication Extension Reviews22
New Dosages/Pack Sizes .22
Other Price Cuts 22
PHARMACOECONOMICS.23
Pharmacoeconomic Requirements..23
Swiss Medical Board .23
Health 2020 Reviews.25
PRICE BUILD UP ...25
Wholesalers .25
Margins ..25
Discounts ...26
Background26
Retail Pharmacies 26
Margins ..26
Fee-for-service Payments .27
Generic Substitution Fees .27
Per-pack Discount .28
Background28
Recent Changes28
NetCare .29
Mail Order/e-Pharmacy .29
Dispensing Doctors ..30
Sales Tax .31
COST CONTAINMENT ..31
Industry Paybacks31
Per-pack Tax .31
Three-year Reviews ..32
Promotional Costs32
Patient Co-payments32
Healthcare .32
Pharmaceuticals 33
Co-payment Exemptions ...34
Complementary Private Insurance 34
Prescribing Controls.34
Monitoring..34
Quality Circles35
Swiss Medical Board .35
E-prescribing..36
Generics...36
Rx-to-OTC Switches 36
Parallel Trade...37
FUTURE DEVELOPMENTS ..37
Outlook.37
Pricing37
Triennial Reviews ..38
Patent Expiry Reviews...39
Reference Price Reimbursement System .39
Health Insurance Premiums ..39
Health 2020 ...39
E-Health Initiatives.40
Hospital Funding41
Rare Diseases ...41
Pharmacies41
Transparency Measures42
TARMED42
NAMES and ADDRESSES 43

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025 Summary Endometriosis is an estrogen-dependent, chronic, inflammatory disease characterized by the appearance and growth of ...

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

United States Diagnostic Imaging Market Outlook to 2022

United States Diagnostic Imaging Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

United States Diagnostic Imaging Market Outlook to 2022 Summary GlobalData’s new report, "United States Diagnostic Imaging Market Outlook to 2022", provides key market data on the United States Diagnostic ...

Global Telemedicine Market

December 2016 $ 4250

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.